Hudson Executive Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$13.5M |
| 2 |
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
|
+$9.23M |
| 3 |
KATE
Kate Spade & Company
KATE
|
+$4.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$18.3M |
| 2 |
CMA
Comerica
CMA
|
+$6.2M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$3.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.3% |
| 2 | Financials | 14.37% |
| 3 | Technology | 12.3% |
| 4 | Consumer Discretionary | 6.62% |
Similar funds
Hudson Executive Capital's Q1 2017 Portfolio in Review
As of Q1 2017, Hudson Executive Capital held 13 positions worth $365M, up 30% from $281M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hudson Executive Capital deployed $53M of net new capital in Q1 2017, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was CORINDUS VASCULAR ROBOTICS, INC: 11,336,154 shares worth $14.8M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 45% a quarter earlier, followed by Financials and Technology.
On the sell side, the most notable exit was Tenet Healthcare, an estimated $18.3M sold.
- Hudson Executive Capital's largest Q1 2017 buy was CORINDUS VASCULAR ROBOTICS, INC: 11,336,154 shares worth $14.8M.
- Hudson Executive Capital added most to AtriCure in Q1 2017, an estimated $13.5M increase.
- Hudson Executive Capital fully exited Tenet Healthcare in Q1 2017, selling an estimated $18.3M.
- Hudson Executive Capital's ten largest holdings make up 100% of its $365M portfolio in Q1 2017.
- Hudson Executive Capital opened 2 new positions and closed 4 in Q1 2017.
- Hudson Executive Capital's portfolio value rose 30% quarter-over-quarter to $365M.
Based on Hudson Executive Capital's 13F filing for Q1 2017, filed 15 May 2017.